Mitsubishi Chemical Group Corporation Share Price

Equities

4188

JP3897700005

Diversified Chemicals

Market Closed - Japan Exchange 07:00:00 25/06/2024 BST 5-day change 1st Jan Change
889 JPY +2.14% Intraday chart for Mitsubishi Chemical Group Corporation +10.16% +2.89%

Financials

Sales 2024 4,387B 27.52B 2,169B Sales 2025 * 4,634B 29.07B 2,292B Capitalization 1,238B 7.77B 612B
Net income 2024 120B 750M 59.14B Net income 2025 * 87.49B 549M 43.26B EV / Sales 2024 0.73 x
Net Debt 2024 1,906B 11.95B 943B Net Debt 2025 * 2,038B 12.79B 1,008B EV / Sales 2025 * 0.71 x
P/E ratio 2024
10.9 x
P/E ratio 2025 *
14.2 x
Employees 68,639
Yield 2024
3.49%
Yield 2025 *
3.7%
Free-Float 93.94%
More Fundamentals * Assessed data
Dynamic Chart
Mitsubishi Chemical Group Disposes of 127 Million Yen Worth of Shares as Restricted Stock Compensation MT
Technip Energies to License Improved OXO Alcohol Technology with Mitsubishi Chemical MT
Mitsubishi Chemical Group Disposes 127 Million Yen Worth of Shares as Restricted Compensation MT
Mitsubishi Chemical Group’s Attributable Profit Jumps 24% in Fiscal 2024 MT
Transcript : Mitsubishi Chemical Group Corporation, 2024 Earnings Call, May 15, 2024
Mitsubishi Chemical Group Corporation Provides Earnings Guidance for the First Half and Full Year Ending March 31, 2025 CI
Mitsubishi Chemical Group Corporation Provides Second Quarter End and Fiscal Year End Dividend Guidance for the Fiscal Year Ending March 31, 2025 CI
Mitsubishi Chemical Group Corporation Announces Fiscal Year-End Dividend for the Fiscal Year Ended March 31, 2024, Payable on June 4, 2024 CI
AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment AN
Mitsubishi Chemical Group Corporation Appoints Yasuo Shimodaira as Executive Vice President, Head of Basic Materials & Polymers, Effective April 1, 2024 CI
Mitsubishi Chemical Group Corporation Announces Retirement of Kouji Eguchi,Representative Corporate Executive Officer, Effective March 31, 2024 CI
Mitsubishi Chemical Group’s Attributable Profit Surges 509.6% in Fiscal Nine Months MT
Transcript : Mitsubishi Chemical Group Corporation, Q3 2024 Earnings Call, Feb 06, 2024
PsiQuantum, Corp., Mitsubishi UFJ Financial Group, Inc. and Mitsubishi Chemical Announces Partnership to Design Energy-Efficient Materials on PsiQuantum?s Fault-Tolerant Quantum Computer CI
Mitsubishi Chemical Group to Sell 80% Stake in Indonesian Unit for Undisclosed Sum MT
More news

Latest transcript on Mitsubishi Chemical Group Corporation

1 day+2.14%
1 week+10.16%
Current month+7.02%
1 month+9.07%
3 months-5.39%
6 months+3.88%
Current year+2.89%
More quotes
1 week
814.00
Extreme 814
889.00
1 month
795.00
Extreme 795
889.00
Current year
795.00
Extreme 795
961.20
1 year
795.00
Extreme 795
987.30
3 years
652.60
Extreme 652.6
1 063.00
5 years
543.40
Extreme 543.4
1 063.00
10 years
433.00
Extreme 433
1 319.50
More quotes
Managers TitleAgeSince
Chief Administrative Officer - -
Chief Administrative Officer - -
Director/Board Member 65 31/03/14
Members of the board TitleAgeSince
Director/Board Member 69 31/05/16
Director/Board Member 60 31/03/21
Director/Board Member 63 31/05/19
More insiders
Date Price Change Volume
25/06/24 889 +2.14% 6 430 900
24/06/24 870.4 +1.03% 6,459,400
21/06/24 861.5 +1.27% 11,037,300
20/06/24 850.7 +1.64% 7,342,100
19/06/24 837 +3.72% 8,702,900

Delayed Quote Japan Exchange, June 25, 2024 at 07:00 am

More quotes
Mitsubishi Chemical Group Corporation (formerly Mitsubishi Chemical Holdings Corporation) is a holding company organized around 5 groups of products: - petrochemical products (32.4% of net sales): ethylene, propylene, benzene, coke, ether, etc.; - performance chemicals and materials (28.6%): performance polymers, food ingredients, polyester films, polyvinyl alcohol-based films, water treatment products, carbon fibres and composite materials, etc.; - industrial gases (23.9%); - healthcare products and equipment (10.1%): pharmaceutical products, reagents and diagnostic instruments, active pharmaceutical ingredients, pharmaceutical intermediates, etc.; - other (5%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
870.4 JPY
Average target price
961.1 JPY
Spread / Average Target
+10.42%
Consensus